Kyongbo Parm

Kyongbo Pharm is a prominent South Korean pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. As a key subsidiary of the Chong Kun Dang Group, the company has built a robust global reputation, exporting its products to more than 30 countries including Japan, Europe, and the United States. Kyongbo Pharm operates advanced manufacturing facilities that are certified by international regulatory agencies such as the US FDA, PMDA, and EDQM, highlighting its commitment to global quality standards. Their extensive product portfolio covers critical therapeutic areas including cardiovascular, gastrointestinal, and anti-infective treatments, with a particular strength in sterile cephalosporin antibiotics. In addition to its core API business, the company is actively expanding into the Contract Development and Manufacturing Organization (CDMO) sector and investing in a pipeline of innovative drug candidates.